i-Pharm Consulting

Have you caught up on the latest edition of i-Pharm Insight yet? We took a deep dive into a topic that's crucial for the pharmaceutical and medical device industry: ventilator recalls. 🗞️ This month, we take a comprehensive look at: 🔍 The root causes behind these recalls 📜 Regulatory responses and actions taken 🏭 Steps manufacturers are taking to enhance product safety Discover how these recalls are driving significant improvements and ensuring the highest standards of care across the medical device sector. Click the link below to read the full newsletter! 🔗 https://lnkd.in/eriiY_8w #iPharmInsights #iPharm #ventilatorrecalls

A new synthetic antibiotic, cresomycin, has shown promising results in early tests against flesh-eating bacteria and other multidrug-resistant pathogens. 💊 Researchers from the University of Illinois Chicago and Harvard University discovered that cresomycin is effective in killing various resistant bacteria strains in cell cultures and mice. This antibiotic works by binding tightly to the bacterial ribosome, disrupting protein synthesis even in bacteria that have developed resistance mechanisms. In tests, cresomycin effectively killed multidrug-resistant bacteria, including those responsible for many healthcare-acquired infections. In mouse models, it significantly improved survival rates and reduced bacterial loads compared to control groups. The research team, supported by a $1.2 million grant from CARB-X, plans to continue developing the compound for potential clinical use. We look forward to seeing how this development in our industry plays out! 💡 #drugdevelopment #iPharm #antibiotic

This week, we have been looking at the latest industry news surrounding ventilator recalls and what this means for the future of the life sciences industry. 🤔 It has raised essential questions about the role of regulatory bodies in preemptively identifying potential issues while supporting innovation. ____________________ Now, we want to hear your thoughts! Vote in the poll below and let us know what you think is most important moving forward. 🗳️ #iPharm #ventilatorrecalls #lifesciences

July's edition of i-Pharm Insights examined the trending issue of ventilator recalls and its implications for the broader medical device industry. Yesterday, we looked a the various issues that have arisen across the industry with ventilators. In the article, we looked at how this could change the future of how our industry uses and implements medical devices. 🔧 Key areas for future focus: 1. Enhanced Quality Management Systems: Proactive quality control throughout the product lifecycle 2. Regulatory Collaboration: Closer partnerships between manufacturers and regulatory bodies 3. Culture of Quality: Embedding a quality-first mindset at all organisational levels 4. Continuous Improvement: Leveraging data and feedback for ongoing device refinement ______________________ Read the full article here: 🔗 https://lnkd.in/dztQtzxW #iPharmInsights #iPharm #medicaldevices

July's edition of i-Pharm Insights looked at the current trending issue in our industry of ventilator recalls and what this means for wider medical devise use within the industry. 🧪 Ventilators are vital for patient care. Recently, FDA Class I recalls have impacted industry leaders Philips, Baxter, and Zoll due to various issues: - Philips: Alarm failures in BiPAP machines - Baxter: Battery charging problems in Life2000 ventilators - Zoll: Updated MRI safety information needed in manuals These problems highlight a critical need for stronger quality control processes. How can we balance innovation with reliability? ______________________ Read the full article here: 🔗 https://lnkd.in/dztQtzxW #iPharmInsights #iPharm #medicaldevices

July's edition of i-Pharm Insights is here! 🗞️ In this month's issue, we dive deep into one of the most pressing topics in the pharmaceutical and medical device industry: ventilator recalls. We explore how these recalls have not only highlighted critical safety concerns but have also become a catalyst for broader quality improvements across the medical device sector. From examining the root causes of these recalls to discussing the regulatory responses and the steps manufacturers are taking to enhance product safety, our newsletter provides valuable insights into the ongoing efforts to ensure the highest standards of care. Click below to read the full newsletter! ⬇️ #iPharmInsights #iPharm #medicaldevices

This month, we had a fantastic EDI Day filled with pottery painting and mindfulness meditation activities at our London office! Why Adult Painting Activities Matter: 🧠 Engaging in art can lower cortisol levels, reducing stress 😊 Painting boosts positive emotions and improves social interactions 🎨 Visual art helps express emotions and thoughts 👥 Group painting fosters essential social connections, enhancing overall well-being Mindfulness Meditation Benefits: 🌍 Mindfulness increases awareness and sensitivity to cultural differences, crucial for inclusivity 🤝 Meditation fosters belonging, especially for diverse employees, improving job satisfaction and retention ❤️ Loving-Kindness Meditation (LKM) reduces implicit bias and increases empathy At i-Pharm, we understand that working in recruitment can be a stressful environment. So, we like to make sure that our colleagues get the time they need to practise mindfulness as a group. Check out some of the highlights from our EDI Day in the attachment! 📸✨ #iPharm #EDI #mentalwellbeing

Last week, we asked for your opinions on the potential risks our industry faces when using AI in the life sciences industry. 🤔 The results are in, with privacy concerns taking the #1 spot with 35% of the votes. The concern for privacy in large data handling is more important than ever now that AI is becoming a much more widely used tool across multiple industries for data analysis. However, with the votes being quite evenly spread, our industry must work together to ensure that all risks of using AI are mitigated from the offset to ensure a brighter future due to AI. 🤖 _____________ Want to read more on this topic? Check our the latest edition of i-Pharm Insights to read everything we have to say about the future of AI in life sciences: 🔗https://lnkd.in/ey2uvGAa Keep your eyes peeled for July's edition of i-Pharm Insights coming very soon! 👀 #AI #lifesciences #iPharm

Biological innovations, combined with advancements in digital technologies like AI, are paving the way for a promising future in the biopharma industry. The industry is poised for substantial growth, projected to hit nearly $1 trillion by 2030. Yet, finding and retaining talent is a significant challenge. Cytiva’s 2023 Biopharma Resilience Index shows a decline in talent pool resilience, highlighting the need for effective academic pipelines and flexible labor regulations. Emerging markets are especially hard-hit. _____________ What does this mean for hiring? It is more important now than ever to use a recruitment firm. Recruiters have a wider reach than those in the industry. We have spoken to the candidates you need before and have a wide network within your industry. Contact us today to discuss how we can help with your biopharma hiring:  📧 contact@i-pharmconsulting.com 🌐 https://lnkd.in/gk4ZnZXp #biopharma #hiring #iPharm

The BBC have reported that a drug used to extend the lifespans of laboratory animals by nearly 25% is being tested on humans, a breakthrough that scientists hope could also slow human ageing. The treated animals were healthier, stronger, and developed fewer cancers than the untreated ones. The drug, currently in human trials, targets interleukin-11, a protein that increases with age and contributes to inflammation and aging. How could this impact human life? 🕢 If the drug proves effective in humans, it could significantly increase lifespan, potentially adding years of healthy life. 💪🏻The drug might help maintain muscle function, reduce cancer incidence, and improve overall health, contributing to better quality of life in older age. 🚫The drug could offer a more feasible way to slow ageing compared to caloric restriction, which is difficult to maintain. Widespread use of anti-aging drugs could have significant societal impacts, including ethical considerations about extending human life and the implications for population dynamics and healthcare systems. 🤔 Leave your thoughts on this interesting topic in the comments section below. 💬 #iPharm #drugdevelopment #drugtesting